Evidence map›Paper›PMID 29484917›Full record

ReviewVirulence2018

Brevundimonas spp: Emerging global opportunistic pathogens.

Michael P Ryan, J Tony Pembroke

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Virulence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06935279 (Bacteria in Atherosclerotic Plaques and Adverse Events), which is not on this map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06935279 completednot on this mapstarted 2024, after this paper: background citation

Bacteria in Atherosclerotic Plaques and Adverse Events

Typeobservational_patient_registrySponsorTang-Du HospitalRan2024 to 2025Enrolled200ConditionsCarotid Artery Stenosis, Cerebral Infarction, Diabetes, BacteriaArmsCarotid Endarterectomy
3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 276 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Insights into the food safety implications of a commercialApplied and environmental microbiology · 2026
    Article
  5. Article
  6. Microbiota variation inMicrobiology spectrum · 2026
    Article
  7. Article
  8. Applied and environmental microbiology · 2026
    Article
  9. Article
  10. New microbes and new infections · 2026
    Review
  11. Article
  12. Article
  13. Detection and Identification ofPathogens (Basel, Switzerland) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael P Ryana Industrial Biochemistry Programme, Department of Chemical Sciences , School of Natural Sciences, University of Limerick , Limerick , Ireland.ORCID 0000-0002-0489-0579
J Tony Pembrokeb Molecular Biochemistry Laboratory, Department of Chemical Sciences , School of Natural Sciences, University of Limerick , Limerick , Ireland.ORCID 0000-0001-9340-7026
University of Limerick · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-fermenting Gram-negative bacteria are problematic in clinical locations, being one of the most prevalent causes of nosocomial infections. Many of these non-fermenting Gram-negative bacteria are opportunistic pathogens that affect patients that are suffering with underlying medical conditions and diseases. Brevundimonas spp., in particular Brevundimonas diminuta and Brevundimonas vesicularis, are a genus of non-fermenting Gram-negative bacteria considered of minor clinical importance. Forty-nine separate instances of infection relating to Brevundimonas spp were found in the scientific literature along with two pseudo-infections. The majority of these instances were infection with Brevundimonas vesicularis (thirty-five cases - 71%). The major condition associated with Brevundimonas spp infection was bacteraemia with seventeen individual cases/outbreaks (35%). This review identified forty-nine examples of Brevundimonas spp. infections have been discussed in the literature. These findings indicate that infection review programs should consider investigation of possible Brevundimonas spp outbreaks if these bacteria are clinically isolated in more than one patient.

Indexed as

BacteremiaCaulobacteraceaeCommunicable Diseases, EmergingDisease OutbreaksGlobal HealthGram-Negative Bacterial InfectionsHumansOpportunistic InfectionsBrevundimonasenvironmental bacterianon-fermenting nosocomial infection

Identifiers

PMID29484917
PMCPMC5955483
OpenAlexW2788823524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.